LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
Quilter Cheviot Appoints Colin Rowe as Head of AdviceBy News Team04/11/2024 Colin Rowe appointed as Quilter Cheviot’s head of advice, pending approval.Rowe to join the executive committee, bringing 20+ years of experience.Quilter Cheviot to streamline financial planning…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
